(Q35230967)

7 August 2017

1 reference

title

Human herpesvirus-6: clinical implications of a recently discovered, ubiquitous agent (English)

1 reference

7 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1322455

Herpesviridae infectious disease

13 September 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1322455

13 September 2022

author name string

C. T. Leach

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1322455

13 September 2022

C. V. Sumaya

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1322455

13 September 2022

N. A. Brown

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1322455

13 September 2022

language of work or name

English

0 references

publication date

1 August 1992

1 reference

The Journal of Pediatrics

7 August 2017

published in

1 reference

7 August 2017

volume

121

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

173-181

1 reference

Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Isolation of human lymphotropic herpesviruses from Uganda.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

A novel lymphotropic herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Molecular studies of HHV-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

CD4 is not the membrane receptor for HHV-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Variations in the replication and antigenic properties of human herpesvirus 6 strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Human herpesvirus 6 harbouring in kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Latent herpesvirus-6 in salivary and bronchial glands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Human herpesvirus 6 in salivary glands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Latent human herpesvirus 6 infection of human monocytes/macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Fall in human herpesvirus 6 seropositivity with age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Age prevalence of antibody to human herpesvirus 6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Antibody prevalence to HBLV (human herpesvirus-6, HHV-6) and suggestive pathogenicity in the general population and in patients with immune deficiency syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

IgG antibodies to human herpesvirus-6 in children and adults and in primary Epstein-Barr virus infections and cytomegalovirus infections [corrected]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Exanthem subitum and antibody to human herpesvirus-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

HHV-6 in Djibouti--an epidemiological survey in young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Prevalence of antibodies to human herpesvirus 6 in different age groups, in children with exanthema subitum, other acute exanthematous childhood diseases, Kawasaki syndrome, and acute infections with other herpesviruses and HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Neutralizing antibodies to human herpesvirus-6 in healthy individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Enzyme-linked immunosorbent assay for detection of IgG antibody to human herpesvirus 6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

High prevalence of antibody to human herpesvirus-6 and decrease in titer with increase in age in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Antibody reactivity with HBLV (HHV-6) in U.S. populations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

High prevalence of antibody to human herpesvirus-6 and seroconversion associated with rash in two infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

The distribution of antibodies to HHV-6 compared with other herpesviruses in young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Role of human herpesvirus 6 infection in infants with exanthema subitum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Human herpesvirus 6 and exanthem subitum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Frequent shedding of human herpesvirus 6 in saliva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Prevalence of antibody to human herpesvirus 6 among blood donors infected with HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Identification of human herpesvirus-6 as a causal agent for exanthem subitum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Production of IgM antibody to HHV6 in reactivation and primary infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Severity of human herpesvirus-6 viremia and clinical findings in infants with exanthem subitum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Roseola infantum (exanthem subitum)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Human herpesvirus type 6 infection (exanthem subitum) without fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Hepatitis due to human herpesvirus-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Fulminant Hepatitis in Primary Human Herpesvirus-6 Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Brief report: primary human herpesvirus 6 infection in a patient following liver transplantation from a seropositive donor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Human herpesvirus-6 infection with liver injury in neonatal hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Clinical and serological features of human herpesvirus-6 infection in three adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Dual antibody rises to cytomegalovirus and human herpesvirus type 6: frequency of occurrence in CMV infections and evidence for genuine reactivity to both viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Human herpesvirus-6 and cross-reactivity with other herpesviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Serological crossreaction of human herpesvirus-6 with cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Human B-lymphotropic virus (human herpesvirus-6).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

The seroepidemiology of human herpesvirus-6 (HHV-6) from a case-control study of leukaemia and lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Lack of correlation between human herpesvirus-6 infection and the course of human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

GM-CSF with ganciclovir for the treatment of CMV retinitis in AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Reactivation of Herpesvirus Type 6 in Children Receiving Bone Marrow Transplants for Leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Meningo-encephalitis associated with HHV-6 related exanthem subitum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Demonstration of HIV-1 and HHV-6 in AIDS-associated retinitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Susceptibility of human herpesvirus 6 to antivirals in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

Characteristics of human herpesvirus-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

7 January 2021

Putative site for the acquisition of human herpesvirus 6 virion tegument

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

7 January 2021

Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

7 January 2021

Seroepidemiology of human herpesvirus 6 infection in normal children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

7 January 2021

Effect of primary Epstein-Barr virus infection on human herpesvirus 6, cytomegalovirus, and measles virus immunoglobulin G titers

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

7 January 2021

Transactivation of human immunodeficiency virus promoter by human herpesvirus 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2981184-9

7 January 2021

10.1016/S0022-3476(05)81184-9

Identifiers

DOI

1 reference

7 August 2017

1 reference